Former Goldman Sachs executive Nomi Prins recently drank the contents of a brand-new type of battery…

To reveal why 5 billionaires are investing in this tiny $4 company behind it.

And how it could unleash a $130 trillion energy revolution.

ALZN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: N/A

Insider Buying (Last 12 Months): $5,110,861.83

Insider Selling (Last 12 Months): $81,200.00

Alzamend Neuro Insider Trading History Chart

Alzamend Neuro Share Price & Price History

^$1.22

▲ +0.03 (2.52%)

As of 10/3/2022 04:59 PM ET

Days: 30 | 90 | 365

A One Stop Shop for Everything Futures Trading

From RJO Futures | Ad

Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!

Download your FREE Technical Analysis Trading Guide Today.

Alzamend Neuro Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/29/2022	Milton C. Ault III	Major Shareholder	Buy	3,500	$1.19	$4,165.00	10,093,667
9/19/2022	Stephan Jackman	CEO	Buy	8,500	$1.23	$10,455.00	8,500
9/14/2022	David J Katzoff	CFO	Buy	10,000	$1.11	$11,100.00	28,000
8/25/2022	Milton C. Ault III	Major Shareholder	Buy	4,900	$0.96	$4,704.00	10,007,567
8/22/2022	Milton C. Ault III	Major Shareholder	Buy	36,000	$0.97	$34,920.00	10,002,667
8/15/2022	Milton C. Ault III	Major Shareholder	Buy	14,000	$1.06	$14,840.00	9,951,667
8/3/2022	Milton C. Ault III	Major Shareholder	Buy	2,000	$0.95	$1,900.00	9,936,667
7/27/2022	Milton C. Ault III	Major Shareholder	Buy	5,700	$0.87	$4,959.00	9,934,667
7/22/2022	Milton C. Ault III	Major Shareholder	Buy	2,300	$0.91	$2,093.00	9,928,967
7/18/2022	Milton C. Ault III	Major Shareholder	Buy	10,000	$0.98	$9,800.00	9,926,667
6/29/2022	Milton C. Ault III	Major Shareholder	Buy	10,000	$0.88	$8,800.00	9,916,667
6/17/2022	Milton C. Ault III	Major Shareholder	Buy	10,000	$0.88	$8,800.00	9,906,667
6/14/2022	Milton C. Ault III	Major Shareholder	Buy	10,000	$0.85	$8,500.00	9,886,667
6/7/2022	Milton C. Ault III	Major Shareholder	Buy	2,000	$0.94	$1,880.00	9,868,667
6/2/2022	Milton C. Ault III	Major Shareholder	Buy	8,000	$0.96	$7,680.00	9,866,667
5/26/2022	Milton C. Ault III	Major Shareholder	Buy	10,000	$0.91	$9,100.00	9,846,667
5/24/2022	Milton C. Ault III	Major Shareholder	Buy	16,100	$0.89	$14,329.00	9,836,667
5/17/2022	Milton C. Ault III	Major Shareholder	Buy	23,900	$0.98	$23,422.00	9,815,567
5/12/2022	Milton C. Ault III	Major Shareholder	Buy	25,000	$0.85	$21,250.00	9,791,667
5/5/2022	Milton C. Ault III	Major Shareholder	Buy	100,000	$1.07	$107,000.00	325,000
4/26/2022	Milton C. Ault III	Major Shareholder	Buy	2,666,667	$1.50	$4,000,000.50	9,666,667
4/22/2022	Milton C. Ault III	Major Shareholder	Buy	75,000	$0.94	$70,500.00	225,000
4/11/2022	Milton C. Ault III	Major Shareholder	Buy	50,000	$1.13	$56,500.00	150,000
3/31/2022	Mark Gustafson	Director	Sell	20,000	$1.21	$24,200.00	60,000
3/18/2022	Milton C. Ault III	Major Shareholder	Buy	100,000	$1.10	$110,000.00
2/24/2022	Milton C. Ault III	Major Shareholder	Buy	22,500	$1.15	$25,875.00
1/27/2022	Milton C. Ault III	Major Shareholder	Buy	2,500	$1.40	$3,500.00
1/24/2022	Milton C. Ault III	Major Shareholder	Buy	5,000	$1.29	$6,450.00
1/18/2022	Milton C. Ault III	Major Shareholder	Buy	7,000	$1.66	$11,620.00
1/14/2022	Milton C. Ault III	Major Shareholder	Buy	3,000	$1.79	$5,370.00
1/7/2022	Milton C. Ault III	Major Shareholder	Buy	3,000	$1.93	$5,790.00
1/5/2022	Milton C. Ault III	Major Shareholder	Buy	2,000	$1.98	$3,960.00
12/23/2021	Milton C. Ault III	Major Shareholder	Buy	1,612	$2.10	$3,385.20
12/20/2021	Milton C. Ault III	Major Shareholder	Buy	25,000	$2.11	$52,750.00
12/17/2021	Milton C. Ault III	Major Shareholder	Buy	13,000	$2.48	$32,240.00
12/14/2021	Mark Gustafson	Director	Sell	20,000	$2.85	$57,000.00
11/30/2021	Milton C. Ault III	Major Shareholder	Buy	5,319	$2.27	$12,074.13
11/22/2021	Milton C. Ault III	Major Shareholder	Buy	15,000	$1.90	$28,500.00
11/8/2021	Milton C. Ault III	Major Shareholder	Buy	145,000	$2.57	$372,650.00
9/14/2021	Milton C. Ault III	Major Shareholder	Buy	5,000	$2.70	$13,500.00	150,000
8/27/2021	Milton C. Ault III	Major Shareholder	Buy	6,000	$2.90	$17,400.00
8/17/2021	Milton C. Ault III	Major Shareholder	Buy	4,000	$3.29	$13,160.00
8/12/2021	Milton C. Ault III	Major Shareholder	Buy	3,400	$3.87	$13,158.00
8/9/2021	Milton C. Ault III	Major Shareholder	Buy	500	$4.05	$2,025.00
8/6/2021	Milton C. Ault III	Major Shareholder	Buy	4,000	$4.07	$16,280.00
8/4/2021	Milton C. Ault III	Major Shareholder	Buy	500	$4.30	$2,150.00
8/2/2021	Milton C. Ault III	Major Shareholder	Buy	1,500	$4.56	$6,840.00
7/30/2021	Milton C. Ault III	Major Shareholder	Buy	1,338,333	$1.51	$2,020,882.83
7/26/2021	Milton C. Ault III	Major Shareholder	Buy	3,500	$4.94	$17,290.00
7/23/2021	Milton C. Ault III	Major Shareholder	Buy	5,000	$5.76	$28,800.00
7/19/2021	Milton C. Ault III	Major Shareholder	Buy	4,000	$5.41	$21,640.00
7/16/2021	Milton C. Ault III	Major Shareholder	Buy	600	$6.23	$3,738.00
7/14/2021	Milton C. Ault III	Major Shareholder	Buy	5,000	$6.74	$33,700.00
7/12/2021	Milton C. Ault III	Major Shareholder	Buy	8,100	$6.15	$49,815.00
7/8/2021	Milton C. Ault III	Major Shareholder	Buy	2,000	$6.08	$12,160.00
7/6/2021	Milton C. Ault III	Major Shareholder	Buy	7,000	$7.07	$49,490.00
6/28/2021	Milton C. Ault III	Major Shareholder	Buy	9,000	$9.61	$86,490.00
6/25/2021	Milton C. Ault III	Major Shareholder	Buy	14,000	$8.79	$123,060.00
6/22/2021	Milton C. Ault III	Major Shareholder	Buy	74,000	$9.29	$687,460.00

A One Stop Shop for Everything Futures Trading

From RJO Futures | Ad

Download your FREE Technical Analysis Trading Guide Today.

SEC Filings (Institutional Ownership Changes) for Alzamend Neuro (NASDAQ:ALZN)

0.95% of Alzamend Neuro stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Alzamend Neuro Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/15/2022	Millennium Management LLC	49,223	$43K	0.0%	-65.4%	0.052%
8/13/2022	Renaissance Technologies LLC	65,131	$56K	0.0%	N/A	0.068%
6/7/2022	Bank of America Corp DE	28,197	$35K	0.0%	N/A	0.031%
5/11/2022	RFG Advisory LLC	250,000	$0.31M	0.0%	N/A	0.277%
5/9/2022	Qube Research & Technologies Ltd	78,465	$97K	0.0%	N/A	0.087%
4/22/2022	Truist Financial Corp	2,314,907	$2.85M	0.0%	N/A	2.569%
1/31/2022	Commonwealth Equity Services LLC	116,666	$0.22M	0.0%	N/A	0.131%
11/16/2021	Schonfeld Strategic Advisors LLC	31,600	$97K	0.0%	N/A	0.036%
11/16/2021	Two Sigma Investments LP	172,913	$0.53M	0.0%	N/A	0.199%
11/16/2021	Warberg Asset Management LLC	14,000	$43K	0.0%	N/A	0.016%
11/15/2021	Sassicaia Capital Advisers LLC	93,762	$0.29M	0.8%	N/A	0.108%
9/17/2021	Virtu Financial LLC	15,402	$0.14M	0.0%	N/A	0.018%
8/16/2021	Cubist Systematic Strategies LLC	23,672	$0.21M	0.0%	N/A	0.028%
8/13/2021	Geode Capital Management LLC	44,600	$0.39M	0.0%	N/A	0.052%
8/11/2021	Susquehanna International Group LLP	57,030	$0.50M	0.0%	N/A	0.067%

Data available starting January 2016

Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001 that is in Phase II clinical trial, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and AL002 that completed preclinical stage, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.

Today's Range

Now: $1.22

$1.19

$1.25

50 Day Range

MA: $1.04

$0.88

$1.35

52 Week Range

Now: $1.22

$0.80

$3.38

Volume

10,888 shs

Average Volume

993,724 shs

Market Capitalization

$116.49 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Alzamend Neuro?: Alzamend Neuro's top insider shareholders include:
Milton C Ault III (Major Shareholder)
Mark Gustafson (Director)
David J Katzoff (CFO)
Stephan Jackman (CEO)
L Mary Smith (Insider)
Learn More about top insider investors at Alzamend Neuro.